Drug intelligence / Profile preview

2,4-dinitrophenyl 2-deoxy-2-fluoro-beta-d-mannopyranoside

Development stage: Unknown
Modality: Small Molecules

Overview

**Description:**\nThis compound is a synthetic glycoside in which a mannose sugar derivative is linked to a dinitrophenyl group. It belongs to the class of O-glycosyl compounds and is primarily used as an experimental tool in biochemical research rather than as a therapeutic agent. Its mechanism of action is not established for any disease or clinical indication; it may be used as an enzyme substrate or inhibitor probe in laboratory settings[1][6]. There are no known primary indications or approved uses for this compound.

Other names: 2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Mannopyranoside(2R,3S,4S,5S,6S)-6-(2,4-dinitrophenoxy)-5-fluoro-2-(hydroxymethyl)oxane-3,4-diol[1][6]

Targets

MANBA (Beta-mannosidase)

Beyond the preview

Go deeper on 2,4-dinitrophenyl 2-deoxy-2-fluoro-beta-d-mannopyranoside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2,4-dinitrophenyl 2-deoxy-2-fluoro-beta-d-mannopyranoside.

Explore the full profile